LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR

Clinical trials for LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets specific genetic flaws in Tough-to-Treat cancers

Disease control Ongoing

This study is testing an oral drug called rogaratinib for adults with advanced sarcoma or a rare stomach tumor called SDH-deficient GIST. The drug aims to block specific proteins that help these cancer cells grow, with the goal of shrinking tumors and controlling the disease. It …

Matched conditions: LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR

Get alerted when new LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOR trials appear

New drug trial targets specific genetic flaws in Tough-to-Treat cancers